<DOC>
	<DOCNO>NCT00289367</DOCNO>
	<brief_summary>The purpose project see whether treatment thyroid hormone , call triiodothyronine T3 , follow open heart surgery reduces risk develop atrial fibrillation .</brief_summary>
	<brief_title>Study T3 Incidence Atrial Fibrillation Patients Undergoing Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>1 . Patients require CABG valve repair/replacement surgery . 2 . Patient must able provide inform consent . 1 . Patients le 18 85 year age . 2 . Patients less 50kg great 120kg . 3 . Patients currently endocrine disorder , exclude diabetes . 4 . Patients currently thyroid dysfunction ( e.g. , hyper hyperthyroidism , goiter , Grave 's disease ) , myxedema , myxedema coma , even treat . 5 . Patients currently receive thyroid replacement therapy . 6 . Patients currently receive Ketamine , levarterenol dietary ( nonfood ) iodine supplementation . 7 . Patients receive investigational drug within previous one month five halflives drug . 8 . Patients pregnant . Pregnancy test do woman childbearing potential . 9 . Patients currently atrial fibrillation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>